You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

SODIUM IODIDE I 123 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Sodium Iodide I 123 patents expire, and when can generic versions of Sodium Iodide I 123 launch?

Sodium Iodide I 123 is a drug marketed by Cardinal Health 418, Curium, and Ge Healthcare. and is included in four NDAs.

The generic ingredient in SODIUM IODIDE I 123 is sodium iodide i-123. There are one thousand four hundred and seventy-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the sodium iodide i-123 profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for SODIUM IODIDE I 123?
  • What are the global sales for SODIUM IODIDE I 123?
  • What is Average Wholesale Price for SODIUM IODIDE I 123?
Summary for SODIUM IODIDE I 123
US Patents:0
Applicants:3
NDAs:4
Finished Product Suppliers / Packagers: 2
Raw Ingredient (Bulk) Api Vendors: 6
Clinical Trials: 18
Patent Applications: 10
What excipients (inactive ingredients) are in SODIUM IODIDE I 123?SODIUM IODIDE I 123 excipients list
DailyMed Link:SODIUM IODIDE I 123 at DailyMed
Drug patent expirations by year for SODIUM IODIDE I 123
Recent Clinical Trials for SODIUM IODIDE I 123

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Stryker EndoscopyPhase 4
University Health Network, TorontoPhase 4
Osaka UniversityPhase 1

See all SODIUM IODIDE I 123 clinical trials

US Patents and Regulatory Information for SODIUM IODIDE I 123

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cardinal Health 418 SODIUM IODIDE I 123 sodium iodide i-123 CAPSULE;ORAL 018671-001 May 27, 1982 AA RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ge Healthcare SODIUM IODIDE I 123 sodium iodide i-123 CAPSULE;ORAL 017630-003 Jan 8, 1993 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Curium SODIUM IODIDE I 123 sodium iodide i-123 CAPSULE;ORAL 071909-001 Feb 28, 1989 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ge Healthcare SODIUM IODIDE I 123 sodium iodide i-123 SOLUTION;ORAL 017630-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.